4
Changes in Ownership
PHIBRO ANIMAL HEALTH CORP Filed Acc 0001144204-18-036764
President and CEO sold 30,000 shares at an average $45.66 ($1,369,800)
- President and CEO acquired 30,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENDHEIM JACK President and CEO | 2018-06-27 | Conversion | +30,000 | 60,000 | I: show line 1 in the form | ||
| BENDHEIM JACK President and CEO | 2018-06-27 | Sale | −10,000 | $45.79 | $457,900 | 50,000 | I: show line 2 in the form |
| BENDHEIM JACK President and CEO | 2018-06-28 | Sale | −10,000 | $45.54 | $455,400 | 40,000 | I: show line 3 in the form |
| BENDHEIM JACK President and CEO | 2018-06-29 | Sale | −10,000 | $45.65 | $456,500 | 30,000 | I: show line 4 in the form |
| Open-market sales · 30,000 sh · avg $45.66 · $1,369,800 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENDHEIM JACK President and CEO | 2018-06-27 | Conversion · Class B Common Stock | −30,000 | 20,365,504 | D: show line 5 in the form |
Loading xslF345X03/tv497555_form4.xml…